Analysis for Pfizer
Analysis summary
Pfizer (PFE) currently has a total score of 32 points, placing it in the weak range. The score is made up of Performance (16), Stability (41) and Trend (57). The profile is clearly uneven: Trend stands out while Performance lags.
Performance scores 16 points (very weak). Least weak metric: 1Y return at 6.8 %. Main drag: 3Y return at -36.8 %.
Stability scores 41 points (neutral). Most supportive metric: volatility (365d, annualized) at 26.8 %. Weaker metric: current drawdown at -55.3 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 57 points (neutral). Key strength: trend strength at 0.76. Weaker metric: 12M momentum at 1.0 %.
Overall, the profile has a clear strength in Trend, while Performance is the main limiter. On a metric level, trend strength stands out, while 3Y return lags.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does Pfizer fit best in FoxScore?
- Pfizer shows a mixed profile: trend is strongest, but performance lags noticeably. Use the sub-scores as a radar, then decide based on the metrics whether the risk/return profile fits you.
- How meaningful is the available history for Pfizer?
- Pfizer currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.